Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.
about
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineThe novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
P2860
Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Limited role for transforming ...... ition in murine glioma models.
@en
type
label
Limited role for transforming ...... ition in murine glioma models.
@en
prefLabel
Limited role for transforming ...... ition in murine glioma models.
@en
P2093
P2860
P356
P1433
P1476
Limited role for transforming ...... bition in murine glioma models
@en
P2093
Edith Willscher
Emad Seyed Sadr
Guido Reifenberger
Hannah Schneider
Hans Binder
Katharina Seystahl
Michael Weller
P2860
P304
P356
10.1093/NEUONC/NOW112
P577
2016-06-10T00:00:00Z